Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | MPNs at ASCO 2022: cytopenic myelofibrosis, non-JAK inhibitor approaches & combination therapy

Ciro Rinaldi, MD, PhD, Lincoln County Hospital, Lincoln, UK, provides an overview of key takeaways in myeloproliferative neoplasms (MPNs) from the American Society of Clinical Oncology (ASCO) Annual Meeting, highlighting cytopenic myelofibrosis as an area of unmet need in the field of MPNs. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.